Rapid target gene validation in complex cancer mouse models using re-derived embryonic stem cells.

Download
Author
Huijbers, IJ; Bin Ali, R; Pritchard, C; Cozijnsen, M; Kwon, M-C; Proost, N; Song, J-Y; de Vries, H; Badhai, J; Sutherland, K; ...Date
2014-02Source Title
EMBO Molecular MedicinePublisher
EMBOUniversity of Melbourne Author/s
Sutherland, KateAffiliation
Medical Biology (W.E.H.I.)Metadata
Show full item recordDocument Type
Journal ArticleCitations
Huijbers, I. J., Bin Ali, R., Pritchard, C., Cozijnsen, M., Kwon, M. -C., Proost, N., Song, J. -Y., de Vries, H., Badhai, J., Sutherland, K., Krimpenfort, P., Michalak, E. M., Jonkers, J. & Berns, A. (2014). Rapid target gene validation in complex cancer mouse models using re-derived embryonic stem cells.. EMBO Mol Med, 6 (2), pp.212-225. https://doi.org/10.1002/emmm.201303297.Access Status
Open AccessOpen Access at PMC
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3927956Abstract
Human cancers modeled in Genetically Engineered Mouse Models (GEMMs) can provide important mechanistic insights into the molecular basis of tumor development and enable testing of new intervention strategies. The inherent complexity of these models, with often multiple modified tumor suppressor genes and oncogenes, has hampered their use as preclinical models for validating cancer genes and drug targets. In our newly developed approach for the fast generation of tumor cohorts we have overcome this obstacle, as exemplified for three GEMMs; two lung cancer models and one mesothelioma model. Three elements are central for this system; (i) The efficient derivation of authentic Embryonic Stem Cells (ESCs) from established GEMMs, (ii) the routine introduction of transgenes of choice in these GEMM-ESCs by Flp recombinase-mediated integration and (iii) the direct use of the chimeric animals in tumor cohorts. By applying stringent quality controls, the GEMM-ESC approach proofs to be a reliable and effective method to speed up cancer gene assessment and target validation. As proof-of-principle, we demonstrate that MycL1 is a key driver gene in Small Cell Lung Cancer.
Export Reference in RIS Format
Endnote
- Click on "Export Reference in RIS Format" and choose "open with... Endnote".
Refworks
- Click on "Export Reference in RIS Format". Login to Refworks, go to References => Import References